TLR4 and myeloid sarcoma: Upon binding the TLR4 on oligodendroglial precursor cells, HERV-W env stimulates release of pro-inflammatory cytokines, inducible nitric oxide synthase, and formation of nitrotyrosine groups leading to reduction of myelin expression in MS lesions (Kremer et al., 2013).